Lleida.net receives its fourth patent in the Middle East
MADRID, Nov. 2, 2022 /PRNewswire/ -- Spanish listed company Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) has received a new patent from the Gulf Cooperation Council (GCC) for its Method for Certifying Delivery of Data Messages to Mobile Terminals.
This patent, the company's 216th, is valid for 20 years.
The Gulf Cooperation Council is a regional body, mainly economic in nature, which brings together the countries of the Middle East: Saudi Arabia, the United Arab Emirates, Qatar, Bahrain, Oman and Kuwait. It is based in Riyadh, the Saudi capital.
This is the fourth patent Lleida.net has received from the GCC.
"Once again, our position in the Middle East continues to consolidate, while the company continues to receive recognition for its R&D contributions to the industry," explained the company's CEO, Sisco Sapena.
With this, the company now has a total of 216 awards for its inventions, in what is one of the most extensive Intellectual Property portfolios in the industry.
More than 60 countries on five continents have granted patents to the company, including the European Union, the United States, China, Russia, India, Mexico, Japan, Colombia, Argentina, Peru, South Africa, Nigeria, Australia and New Zealand.
Lleida.net is listed on the OTCQX index in New York, on Euronext Growth in Paris and on BME Growth in Madrid.
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...